Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical Industries "
Mergers & Acquisitions
Generic drug maker Mylan $26bn hostile bid for peer Perrigo looked unlikely to succeed, a few hours before it was set to expire, a...
Business
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
Business
Perrigo Company (NYSE:PRGO; TASE:PRGO) CEO Joseph Papa is ready to talk with Mylan N.V. (MYL) about its takeover bid, but at a higher price....
Business
Deal to give Perrigo manufacturing technology for softgel products
Business
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Business
Mylan's filing on executive compensation reveals much higher pay than at Teva.
Court
The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015. The US Supreme Court has ruled in favor of...
Business
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Drug development...